Your browser doesn't support javascript.
loading
Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022.
Kim, Sara S; Chung, Jessie R; Talbot, H Keipp; Grijalva, Carlos G; Wernli, Karen J; Kiniry, Erika; Martin, Emily T; Monto, Arnold S; Belongia, Edward A; McLean, Huong Q; Gaglani, Manjusha; Mamawala, Mufaddal; Nowalk, Mary Patricia; Moehling Geffel, Krissy; Tartof, Sara Y; Florea, Ana; Lee, Justin S; Tenforde, Mark W; Patel, Manish M; Flannery, Brendan; Bentz, Meghan L; Burgin, Alex; Burroughs, Mark; Davis, Morgan L; Howard, Dakota; Lacek, Kristine; Madden, Joseph C; Nobles, Sarah; Padilla, Jasmine; Sheth, Mili.
Afiliação
  • Kim SS; Centers for Disease Control and Prevention Atlanta Georgia USA.
  • Chung JR; Centers for Disease Control and Prevention Atlanta Georgia USA.
  • Talbot HK; Vanderbilt University Medical Center Nashville Tennessee USA.
  • Grijalva CG; Vanderbilt University Medical Center Nashville Tennessee USA.
  • Wernli KJ; Kaiser Permanente Washington Health Research Institute Seattle Washington USA.
  • Kiniry E; Kaiser Permanente Washington Health Research Institute Seattle Washington USA.
  • Martin ET; University of Michigan School of Public Health Ann Arbor Michigan USA.
  • Monto AS; University of Michigan School of Public Health Ann Arbor Michigan USA.
  • Belongia EA; Marshfield Clinic Research Institute Marshfield Wisconsin USA.
  • McLean HQ; Marshfield Clinic Research Institute Marshfield Wisconsin USA.
  • Gaglani M; Baylor Scott and White Health Temple Texas USA.
  • Mamawala M; Texas A&M University College of Medicine Temple Texas USA.
  • Nowalk MP; Baylor Scott and White Health Temple Texas USA.
  • Moehling Geffel K; University of Pittsburgh Schools of Health Sciences Pittsburgh Pennsylvania USA.
  • Tartof SY; University of Pittsburgh Schools of Health Sciences Pittsburgh Pennsylvania USA.
  • Florea A; Kaiser Permanente Southern California Pasadena California USA.
  • Lee JS; Kaiser Permanente Southern California Pasadena California USA.
  • Tenforde MW; Centers for Disease Control and Prevention Atlanta Georgia USA.
  • Patel MM; Centers for Disease Control and Prevention Atlanta Georgia USA.
  • Flannery B; Centers for Disease Control and Prevention Atlanta Georgia USA.
  • Burgin A; Centers for Disease Control and Prevention Atlanta Georgia USA.
  • Burroughs M; Vanderbilt University Medical Center Nashville Tennessee USA.
  • Davis ML; Kaiser Permanente Washington Health Research Institute Seattle Washington USA.
  • Howard D; University of Michigan School of Public Health Ann Arbor Michigan USA.
  • Lacek K; Marshfield Clinic Research Institute Marshfield Wisconsin USA.
  • Madden JC; Baylor Scott and White Health Temple Texas USA.
  • Nobles S; Texas A&M University College of Medicine Temple Texas USA.
  • Padilla J; University of Pittsburgh Schools of Health Sciences Pittsburgh Pennsylvania USA.
  • Sheth M; Kaiser Permanente Southern California Pasadena California USA.
Influenza Other Respir Viruses ; 16(6): 975-985, 2022 11.
Article em En | MEDLINE | ID: mdl-36825251
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pacientes Ambulatoriais / COVID-19 Tipo de estudo: Guideline / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Influenza Other Respir Viruses Assunto da revista: VIROLOGIA Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pacientes Ambulatoriais / COVID-19 Tipo de estudo: Guideline / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Influenza Other Respir Viruses Assunto da revista: VIROLOGIA Ano de publicação: 2022 Tipo de documento: Article